leftspacer middlespacer rightspacer
Media Menu
Featured Material

MAPS Bulletin Summer 2014: Research Edition
Media > LSD and Psilocybin
December 5, 2007


Dr. Peter Gasser’s MAPS-sponsored study evaluating LSD-assisted psychotherapy for subjects with anxiety secondary to advanced-stage illness received final approval from the BAG (Swiss DEA) on December 5,  Ethics Committee (Swiss IRB equivalent) approval on October 30 and SwissMedic (Swiss FDA equivalent) clearance on November 8.  This study—the first to evaluate LSD’s therapeutic applications in over 35 years—will be initiated in early 2008.

Back to LSD and Psilocybin Research

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.